MétaCan
Menu
Back to cohort
Record W4410572324 · doi:10.3389/fneur.2025.1583892

Long-term outcomes in leucine-rich glioma inactivated-1 autoimmune encephalitis and associated biomarkers of inflammation and neuronal and glial injury

2025· article· en· W4410572324 on OpenAlexaboutno aff
Tyler L. Borko, Phillip Winters, Kelli M. Money, Stefan Sillau, Sadie Eggmann, Sean Selva, Alanna Ritchie, Ryan Kammeyer, Gregory P. Owens, Jeffrey L. Bennett, Amanda L. Piquet

Bibliographic record

VenueFrontiers in Neurology · 2025
Typearticle
Languageen
FieldMedicine
TopicAutoimmune Neurological Disorders and Treatments
Canadian institutionsnot available
Fundersnot available
KeywordsAutoimmune encephalitisInflammationGliomaMedicineEncephalitisMicrogliaNeuroinflammationImmunologyNeuroscienceBiologyCancer researchVirus

Abstract

fetched live from OpenAlex

Introduction: Leucine-rich glioma inactivated 1 (LGI1) autoimmune encephalitis (AE) is characterized by seizures, as well as cognitive, memory, and behavioral disturbances. Blood-based biomarkers for inflammation and neuronal and glial injury have been evaluated as potential markers of disease severity and prognosis in AE. Methods: Patients diagnosed with LGI1 AE, confirmed by cell-based assay, were enrolled and followed prospectively to gather plasma samples for biomarker testing. Biomarkers of neuronal and glial injury included plasma neurofilament light chain (NfL), glial fibrillary acidic protein (GFAP), ubiquitin c-terminal hydrolase L1 (UCHL-1), tau, and cytokine markers of inflammation. Biomarker data were logarithmically transformed and analyzed using longitudinal regression with the ratio of means between LGI1 AE and non-inflammatory controls. Clinical data were collected and correlated with blood-based biomarkers to assess their relationship to disease severity and long-term outcomes. Results: Twenty-one LGI1 AE patients were enrolled from October 2018 to April 2024, and 16 migraine headache patients (56.3% male; average age: 58 years) served as non-inflammatory controls. One LGI1 AE patient in our cohort had a clinical relapse. Modified Rankin Score (mRS) and Montreal Cognitive Assessment (MoCA) improved over time. The mRS at symptom onset was 3.34 and dropped to 0.56 in a 5-year follow-up. Mean MoCA scores were 18.45 at the onset and increased to 29.40 in the 6-year follow-up. The model estimated geometric mean plasma NfL values at disease diagnosis to be 11.86 pg/mL; it was estimated to be 6.07 pg/mL when compared to non-inflammatory controls. The model also estimated the plasma GFAP values to be 77.70 pg/mL; it was estimated to be 36.26 pg/mL when compared to non-inflammatory controls. The trend of clinical improvement is paralleled with a slow decline in NfL and GFAP levels, returning to levels like our control population after 6 and 3 years, respectively. MoCA scores tended to recover more quickly in patients presenting with lower Nfl scores at symptom onset. Conclusion: Improved clinical symptoms were correlated with improvements in initially high NfL and GFAP levels. In one patient with a clinical relapse, NfL and GFAP levels increased. NfL and GFAP may be useful biomarkers of disease progression in patients with LGI1 AE. However, additional studies are needed to better understand the effects of immunotherapy.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.004

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0010.000
Scholarly communication0.0010.001
Open science0.0000.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.008
GPT teacher head0.262
Teacher spread0.253 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueFrontiers in NeurologySame topicAutoimmune Neurological Disorders and TreatmentsFrench-language works237,207